Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Entero Therapeutics (ENTO)
NASDAQ:ENTO
RESEARCH TOOLSreports
Holding ENTO?
Track your performance easily
Entero Therapeutics (ENTO) Ownership Overview
3.69% Insiders
0.43% Mutual Funds
0.68% Other Institutional Investors
0.10% ETFs
95.11% Public Companies and
Individual Investors
The ownership structure of Entero Therapeutics (ENTO) stock is a mix of institutional, retail, and individual investors. Approximately 1.21% of the company’s stock is owned by Institutional Investors, 3.69% is owned by Insiders, and 95.11% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 10, 2024 | Sarah Romano Cfo | xxxxxxxxxxxxx | $209 |
| Jul 03, 2024 | Sarah Romano Cfo | xxxxxxxxxxxxx | $664 |
| Jul 03, 2024 | James Sapirstein Chairman & Ceo,director | xxxxxxxxxxxxx | $1379 |
| Apr 03, 2024 | Sarah Romano Cfo | xxxxxxxxxxxxx | $317 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 35,816 | Insider | 0.75% | 22,564 | |
| 25,329 | Insider | 0.53% | 15,957 | |
| 20,248 | Insider | 0.43% | 12,756 | |
| 20,240 | Insider | 0.43% | 12,751 | |
| 20,237 | Insider | 0.43% | 12,749 | |
| 19,937 | Insider | 0.42% | 12,560 | |
| 18,014 | Insider | 0.38% | 11,349 | |
| 16,055 | Institution | 0.34% | 10,115 | |
| 15,400 | Insider | 0.32% | 9,702 | |
| 4,535 | Institution | 0.10% | 2,857 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,055 | Institution | 0.34% | 10,115 | |
| 4,535 | Institution | 0.10% | 2,857 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,535 | Institution | 0.10% | 2,903 |
FAQ
Who Owns Entero Therapeutics (ENTO)?
According to the latest TipRanks data, approximately 0.68% of the company's stock is held by institutional investors, 3.69% is held by insiders, and 95.11% is held by retail investors.
What percentage of Entero Therapeutics (ENTO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.68% of Entero Therapeutics (ENTO) stock is held by institutional investors.
What percentage of Entero Therapeutics (ENTO) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.11% of Entero Therapeutics (ENTO) stock is held by retail investors.
Who owns the most shares of Entero Therapeutics (ENTO)?
James Sapirstein owns the most shares of Entero Therapeutics (ENTO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.